EFFECTIVE ASTHMA MANAGEMENT IN PRIMARY CARE: Severity Assessment, Guidelines, and New Therapy Options

Friday, 11/18 – 8:00am – 9:20am

Overview

Patients with severe, persistent asthma (~4%-10% of all asthma cases) have the highest risk of morbidity and mortality. They contribute significantly to the economic burden of asthma and represent an unmet need in asthma therapy.

Physicians currently use a step-wise, trial-and-error method to determine the best treatment strategy for asthma patients who are not responding well to inhaled corticosteroids (ICS). Recent studies have created a better understanding of the different pathways and mechanisms of inflammation in asthma and suggest that targeted therapies (using biomarkers of inflammation) can improve outcomes in patients with poorly controlled asthma.

Learning Objectives

  • Accurately assess asthma severity using practical biomarkers of pathogenesis and validated tools to stratify and better manage patients
  • Provide guideline-concordant care for patients with asthma, including incorporation of the latest clinical evidence of the MOAs and safety and efficacy profiles of biologic agents and specialist referrals when necessary
  • Engage the entire care team, especially patients and nurses, to effectively communicate management plans that incorporate pharmacologic and nonpharmacologic strategies to improve disease understanding and adherence to treatment

Supporter

This activity is supported by an independent educational grant from AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., and Novartis Pharmaceuticals Corporation.

Accreditation Information

Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Rockpointe. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points [and patient safety MOC credit] in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

AAFP: This live activity, EFFECTIVE ASTHMA MANAGEMENT IN PRIMARY CARE: Severity Assessment, Guidelines, and New Therapy Options, from 9/29/17 – 11/18/17, has been reviewed and is acceptable for up to 1.25 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Information


Jonathan Corren, MD
Associate Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA